Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	706.76	519.86	143.53	83.83	52.6	46.76
Cash & Short-Term Investments	706.76	519.86	143.53	83.83	52.6	46.76
Cash Growth	41.24%	262.20%	71.22%	59.38%	12.48%	-3.01%
Accounts Receivable	274.34	338.14	335.75	78.66	27.92	43.27
Other Receivables	-	-	-	40.02	28.3	16.37
Receivables	274.34	338.14	335.75	208.19	140.35	134.14
Inventory	392.96	254.53	221.22	172.55	160.63	111.24
Prepaid Expenses	-	-	-	1.9	0.49	0.27
Other Current Assets	-	-	-	14.14	4.35	8.67
Total Current Assets	1,374	1,113	700.49	480.61	358.41	301.08
Property, Plant & Equipment	94.01	86.48	63.5	54.63	44.49	44.17
Long-Term Investments	6.49	6.49	6.49	6.49	6.49	6.49
Other Intangible Assets	6.1	8.83	12.46	16.1	19.73	23.37
Long-Term Deferred Tax Assets	3	2.72	2.72	2.47	2.47	2.32
Other Long-Term Assets	0	-	-	0	-	-
Total Assets	1,484	1,217	785.66	560.29	431.58	377.41
Accounts Payable	613.54	694.28	589.12	461.44	401.98	341.21
Accrued Expenses	16.18	13.89	12.34	10.15	9.34	13.74
Short-Term Debt	10.59	69.27	10.98	4.73	5.36	7.4
Current Unearned Revenue	0.09	0.09	0.09	0.09	-	0.09
Other Current Liabilities	78	178.43	64.27	45.68	50.6	76.07
Total Current Liabilities	718.4	955.97	676.8	522.08	467.28	438.52
Long-Term Debt	102.24	109.54	2.34	-	-	-
Long-Term Deferred Tax Liabilities	2.45	2.45	1.57	1.57	1.37	1.37
Other Long-Term Liabilities	-	-	-	-	1.11	16.39
Total Liabilities	823.09	1,068	680.7	523.65	469.77	456.28
Common Stock	227.5	56.25	56.25	56.25	56.25	56.25
Retained Earnings	429.59	89.34	45.61	-22.7	-97.52	-138.2
Comprehensive Income & Other	3.49	3.49	3.09	3.09	3.09	3.09
Shareholders' Equity	660.58	149.08	104.95	36.64	-38.18	-78.86
Total Liabilities & Equity	1,484	1,217	785.66	560.29	431.58	377.41
Total Debt	112.82	178.82	13.32	4.73	5.36	7.4
Net Cash (Debt)	593.94	341.04	130.21	79.1	47.23	39.36
Net Cash Growth	108.05%	161.92%	64.62%	67.45%	20.02%	-15.55%
Net Cash Per Share	26.11	60.63	23.15	14.06	-	7.00
Filing Date Shares Outstanding	22.75	5.63	5.63	5.63	-	5.63
Total Common Shares Outstanding	22.75	5.63	5.63	5.63	-	5.63
Working Capital	655.67	156.56	23.7	-41.47	-108.87	-137.44
Book Value Per Share	29.04	26.50	18.66	6.51	-	-14.02
Tangible Book Value	654.48	140.25	92.49	20.55	-57.92	-102.23
Tangible Book Value Per Share	28.77	24.93	16.44	3.65	-	-18.17
Land	0.59	0.59	0.59	0.59	0.59	0.59
Buildings	99.35	93.19	60.56	60.56	59.6	59.36
Machinery	174.7	148.08	141.61	141.61	140.68	139.51
Construction In Progress	18	20.05	38.51	27.54	16.08	11.43

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.